Revision 43 for 'Gorlin-Goltz syndrome'

All Revisions - View changeset

Gorlin-Goltz syndrome

Gorlin-Goltz syndrome also known as the basal cell nevus syndrome, is a phakomatosis

Epidemiology

The condition is thought to occur in ~ 1 in 60,000 live births while 0.4% of patients with a basal cell carcinoma are estimated to have Gorlin syndrome. ~ 2% and 22% of patients with a basal cell carcinoma younger than 45 years and 19 years of age respectively are estimated to have the syndrome. 

Genetics

It is an autosomal dominant syndrome with complete penetrance and variable expressivity. 35 - 50% of affected individuals are due to new mutations. It is related to mutation in PTCH tumor suppressor gene on chromosome 9. Individuals with the syndrome are sensitive to ionizing radiation.

Diagnostic criteria

clinical diagnosis can be made using major and minor criteria. To make the diagnosis, either two major or, one major and two minor criteria must be met.

Major criteria
  • basal cell cancers : > 2 or 1 under the age 20
  • odontogenic keratocysts (see case 1)
  • palmar pits : 3 or more
  • bilamellar calcification of the falx cerebri
  • rib anomalies : bifid rib (see image), fused, splayed
  • first degree relative with Gorlin syndrome
Minor criteria

Clinical features

Historical context

It was first described by R.J Gorlin and R.W. Goltz in 1960 2.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.